Researchers at Gladstone Institutes reported discovery of two genes that help certain individuals maintain long‑term HIV remission without daily antiretroviral therapy. The work maps molecular mechanisms that appear to ‘lock’ HIV within infected immune cells and sustain viral suppression in the absence of ART. The study combines genomic and functional assays to implicate specific host factors that modulate latency and immune control. Investigators positioned the findings as potential targets for therapies aimed at achieving durable remission or functional cures, noting that translating genetic insights into interventions will require extensive preclinical and clinical validation.